Eczema drug shows promise in repairing Kids' skin barrier
NCT ID NCT04718870
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 28 times
Summary
This study looked at how the medication dupilumab changes the skin barrier in 41 children aged 6 to 12 with moderate to severe eczema. Researchers measured water loss from the skin to see if the treatment helps repair the skin's protective layer. The goal was to understand how dupilumab works beyond just easing symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS, ATOPIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number :8260001
Sheffield, S10 2TH, United Kingdom
-
Investigational Site Number :8400001
Denver, Colorado, 80206, United States
-
Investigational Site Number :8400002
Los Angeles, California, 90027, United States
Conditions
Explore the condition pages connected to this study.